Androstadienes Concept

subject area of

• <p>Cost-Effectiveness Analysis of a Once-Daily Single-Inhaler Triple Therapy for Patients with Chronic Obstructive Pulmonary Disease (COPD) Using the FULFIL Trial: A Spanish Perspective</p>  Academic Article
• <p>Cost-Effectiveness Of Once-Daily Single-Inhaler Triple Therapy In COPD: The IMPACT Trial</p>  Academic Article
• A Possible Link between Fluticasone Propionate and Tics in Pediatric Asthmatics  Academic Article
• A Response to: Letter to the Editor Regarding “Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Triple Therapy Compared with Other Therapies for the Treatment of COPD: A Network Meta-analysis”  Academic Article
• A review of exemestane in the management of breast cancer  Academic Article
• Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy  Academic Article
• Actin filaments participate in the relocalization of phosphatidylinositol3-kinase to glucose transporter-containing compartments and in the stimulation of glucose uptake in 3T3-L1 adipocytes  Academic Article
• Active site labeling of the gentamicin resistance enzyme AAC(6')-APH(2") by the lipid kinase inhibitor wortmannin  Academic Article
• Akt Is Activated in Response to an Apoptotic Signal  Academic Article
• Anti-pneumococcal deficits of monocyte-derived macrophages from the advanced-age, frail elderly and related impairments in PI3K-AKT signaling  Academic Article
• Aromatase Inhibitor Exemestane has Antiproliferative Effects on Human Mesothelioma Cells  Academic Article
• Aromatase inhibitors in adjuvant therapy for hormone receptor positive breast cancer: A systematic review  Academic Article
• Benefit of Prompt versus Delayed Use of Single-Inhaler Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Following a COPD Exacerbation  Academic Article
• Bone density and structure in healthy postmenopausal women treated with exemestane for the primary prevention of breast cancer: a nested substudy of the MAP.3 randomised controlled trial  Academic Article
• COPD Exacerbations, Costs, and Health Care Resource Utilization Before and After Initiation of Fluticasone Furoate/Umeclidinium/Vilanterol in Routine Care in the USA  Academic Article
• COST-effectiveness of salmeterol/fluticasone propionate combination (Advair®) in uncontrolled asthma in Canada  Academic Article
• Canadian Economic Evaluation of Budesonide-Formoterol as Maintenance and Reliever Treatment in Patients with Moderate to Severe Asthma  Academic Article
• Comparison of the Effect of Low-Dose Ciclesonide and Fixed-Dose Fluticasone Propionate and Salmeterol Combination on Long-term Asthma Control  Academic Article
• Competing risks of death in women treated with adjuvant aromatase inhibitors for early breast cancer on NCIC CTG MA.27  Academic Article
• Control of Motoneuron Survival by Angiogenin  Academic Article
• Cost-Effectiveness of Single- versus Multiple-Inhaler Triple Therapy in a UK COPD Population: The INTREPID Trial  Academic Article
• Cost-effectiveness of umeclidinium as add-on to ICS/LABA therapy in COPD: A UK perspective  Academic Article
• Effect of Everolimus on Bone Marker Levels and Progressive Disease in Bone in BOLERO-2  Academic Article
• Effect of adjunct fluticasone propionate on airway physiology during rest and exercise in COPD  Academic Article
• Effect of visceral metastases on the efficacy and safety of everolimus in postmenopausal women with advanced breast cancer: Subgroup analysis from the BOLERO-2 study  Academic Article
• Effects of a Short Course of Inhaled Corticosteroids in Noneosinophilic Asthmatic Subjects  Academic Article
• Effects of adjuvant exemestane versus anastrozole on bone mineral density for women with early breast cancer (MA.27B): a companion analysis of a randomised controlled trial  Academic Article
• Effects of inhaled fluticasone propionate on CTLA-4-positive CD4+CD25+ cells in induced sputum in mild asthmatics  Academic Article
• Effects of intranasal fluticasone and salmeterol on allergen-induced nasal responses  Academic Article
• Efficacy and Safety of Fluticasone Furoate/Vilanterol Compared With Fluticasone Propionate/Salmeterol Combination in Adult and Adolescent Patients With Persistent Asthma  Academic Article
• Efficacy and safety of fluticasone furoate 100 μg once-daily in patients with persistent asthma: A 24-week placebo and active-controlled randomised trial  Academic Article
• Efficacy and safety of once-daily fluticasone furoate 50 mcg in adults with persistent asthma: a 12-week randomized trial  Academic Article
• Efficacy and tolerability of fluticasone propionate nasal drops 400 μg once daily compared with placebo for the treatment of bilateral polyposis in adults  Academic Article
• Efficacy of fluticasone on cough  Academic Article
• Eosinophilic bronchitis in asthma: A model for establishing dose-response and relative potency of inhaled corticosteroids  Academic Article
• Evaluation of fluticasone propionate (500 μg day−1) administered either as dry powder via a Diskhaler® inhaler or pressurized inhaler and compared with beclomethasone dipropionate (1000 μg day−1) administered by pressurized inhaler  Academic Article
• Everolimus Plus Exemestane in Postmenopausal Patients with HR+ Breast Cancer: BOLERO-2 Final Progression-Free Survival Analysis  Academic Article
• Everolimus in Postmenopausal Hormone-Receptor–Positive Advanced Breast Cancer  Academic Article
• Everolimus plus exemestane for hormone-receptor-positive, human epidermal growth factor receptor-2-negative advanced breast cancer: overall survival results from BOLERO-2  Academic Article
• Exemestane Versus Anastrozole in Postmenopausal Women With Early Breast Cancer: NCIC CTG MA.27—A Randomized Controlled Phase III Trial  Academic Article
• First-line treatment of seasonal (ragweed) rhinoconjunctivitis. A randomized management trial comparing a nasal steroid spray and a nonsedating antihistamine.  Academic Article
• Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Triple Therapy Compared with Other Therapies for the Treatment of COPD: A Network Meta-Analysis  Academic Article
• Fluticasone Furoate–Vilanterol 100-25 mcg Compared with Fluticasone Furoate 100 mcg in Asthma: A Randomized Trial  Academic Article
• Fluticasone furoate (FF)/vilanterol (100/25 mcg or 200/25 mcg) or FF (100 mcg) in persistent asthma  Academic Article
• Fluticasone furoate nasal spray consistently and significantly improves both the nasal and ocular symptoms of seasonal allergic rhinitis: a review of the clinical data  Academic Article
• Fluticasone furoate nasal spray is the only intranasal corticosteroid to reduce the ocular symptoms of seasonal allergic rhinitis consistently  Academic Article
• Fluticasone furoate nasal spray reduces symptoms of uncomplicated acute rhinosinusitis: a randomised placebo-controlled study  Academic Article
• Fluticasone furoate/vilanterol versus fluticasone propionate in patients with asthma and exercise-induced bronchoconstriction  Academic Article
• Genome-Wide Associations and Functional Genomic Studies of Musculoskeletal Adverse Events in Women Receiving Aromatase Inhibitors  Academic Article
• Health-related quality of life and disease symptoms in postmenopausal women with HR⁺, HER2⁻advanced breast cancer treated with everolimus plus exemestane versus exemestane monotherapy  Academic Article
• Health-related quality of life of patients with advanced breast cancer treated with everolimus plus exemestane versus placebo plus exemestane in the phase 3, randomized, controlled, BOLERO-2 trial  Academic Article
• Impact of Inhaled Salmeterol/Fluticasone Propionate Combination Product versus Budesonide on the Health-Related Quality of Life of Patients with Asthma  Academic Article
• Impact of adherence to treatment with fluticasone propionate/salmeterol in asthma patients  Academic Article
• Impact of adherence to treatment with tiotropium and fluticasone propionate/salmeterol in chronic obstructive pulmonary diseases patients  Academic Article
• Insulin Attenuates Apoptosis and Exerts Anti-Inflammatory Effects in Endotoxemic Human Macrophages  Academic Article
• Integrated safety and efficacy analysis of once-daily fluticasone furoate for the treatment of asthma  Academic Article
• Interleukins 4 and 13 Increase Intestinal Epithelial Permeability by a Phosphatidylinositol 3-Kinase Pathway  Academic Article
• Multiple roles of phosphatidylinositol 3-kinase in regulation of glucose transport, amino acid transport, and glucose transporters in L6 skeletal muscle cells  Academic Article
• OCULAR SYMPTOM EFFICACY AND INTRANASAL CORTICOSTEROIDS  Academic Article
• Once-Daily Triple Therapy in Patients with Advanced COPD: Healthcare Resource Utilization Data and Associated Costs from the FULFIL Trial  Academic Article
• Once-daily fluticasone furoate (FF)/vilanterol reduces risk of severe exacerbations in asthma versus FF alone  Academic Article
• Once-daily fluticasone furoate alone or combined with vilanterol in persistent asthma  Academic Article
• Once‐daily fluticasone furoate 50 mcg in mild‐to‐moderate asthma: a 24‐week placebo‐controlled randomized trial  Academic Article
• Osteoporosis therapy and outcomes for postmenopausal patients with hormone receptor-positive breast cancer: NCIC CTG MA.27  Academic Article
• Patient-reported predictors of early treatment discontinuation: treatment-related symptoms and health-related quality of life among postmenopausal women with primary breast cancer randomized to anastrozole or exemestane on NCIC Clinical Trials Group (CCTG) MA.27 (E1Z03)  Academic Article
• Pharmacoeconomics in Pediatric Asthma  Academic Article
• Predictors of a more favourable response to combined therapy with salmeterol and fluticasone as initial maintenance therapy in asthma  Academic Article
• Protection by budesonide and fluticasone on allergen-induced airway responses after discontinuation of therapy  Academic Article
• Protective Effects of Fluticasone on Allergen-Induced Airway Responses and Sputum Inflammatory Markers  Academic Article
• Quality of life questionnaires: Does statistically significant = clinically important?  Academic Article
• Randomised controlled study of early use of inhaled corticosteroid in preterm infants with respiratory distress syndrome  Academic Article
• Regulation of SR-BI-mediated selective lipid uptake in Chinese hamster ovary-derived cells by protein kinase signaling pathways  Academic Article
• Risk of new onset diabetes mellitus in patients with asthma or COPD taking inhaled corticosteroids  Academic Article
• Risks of Pneumonia in Patients with Asthma Taking Inhaled Corticosteroids  Academic Article
• Safety and Efficacy of Everolimus With Exemestane vs. Exemestane Alone in Elderly Patients With HER2-Negative, Hormone Receptor–Positive Breast Cancer in BOLERO-2  Academic Article
• Safety and tolerability of the novel inhaled corticosteroid fluticasone furoate in combination with the β₂agonist vilanterol administered once daily for 52 weeks in patients ≥12 years old with asthma: a randomised trial  Academic Article
• Severe prolonged cholestatic hepatitis caused by exemestane  Academic Article
• Should combination therapy with inhaled corticosteroids and long-acting beta2-agonists be prescribed as initial maintenance treatment for asthma?  Academic Article
• Significant variability in response to inhaled corticosteroids for persistent asthma  Academic Article
• Single-Inhaler Triple Therapy in Patients with Advanced COPD: Bayesian Modeling of the Healthcare Resource Utilization Data and Associated Costs from the IMPACT Trial  Academic Article
• Single-inhaler fluticasone furoate/umeclidinium/vilanterol versus fluticasone furoate/vilanterol plus umeclidinium using two inhalers for chronic obstructive pulmonary disease: a randomized non-inferiority study  Academic Article
• Stimulation of Glucose Uptake by the Natural Coenzyme α-Lipoic Acid/Thioctic Acid: Participation of Elements of the Insulin Signaling Pathway  Academic Article
• Symptoms and Cancer Outcome in Adjuvant Endocrine Therapy for Breast Cancer: Why Are They Associated?  Academic Article
• Systemic Effect Comparisons of Six Inhaled Corticosteroid Preparations  Academic Article
• Systemic Therapy in Men With Metastatic Castration-Resistant Prostate Cancer: American Society of Clinical Oncology and Cancer Care Ontario Clinical Practice Guideline  Academic Article
• The inhibition of endocytosis affects HDL-lipid uptake mediated by the human scavenger receptor class B type I  Academic Article
• Tiotropium in Combination with Placebo, Salmeterol, or Fluticasone–Salmeterol for Treatment of Chronic Obstructive Pulmonary Disease  Academic Article
• Tolerability of a Salmeterol Xinafoate/Fluticasone Propionate Hydrofluoroalkane Metered-Dose Inhaler in Adolescent and Adult Patients with Persistent Asthma: A 52-Week, Open-Label, Stratified, Parallel-Group, Multicenter Study  Academic Article
• Treatment-Associated Musculoskeletal and Vasomotor Symptoms and Relapse-Free Survival in the NCIC CTG MA.27 Adjuvant Breast Cancer Aromatase Inhibitor Trial  Academic Article
• Variability of sputum inflammatory cells in asthmatic patients receiving corticosteroid therapy: A prospective study using multiple samples  Academic Article
• Vitamin D Levels, Vitamin D Receptor Polymorphisms, and Inflammatory Cytokines in Aromatase Inhibitor-Induced Arthralgias: An Analysis of CCTG MA.27  Academic Article